Access to anti-retroviral drugs, female (%) in Laos
Laos: Access to anti-retroviral drugs, female (%) was 71.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Laos, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Laos stood at 71.0%. That is the highest value across all 24 years on record.
That represents a change of up 6.0% on the previous year and up 115.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Laos peaked at 71.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Laos 81st out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Laos, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 4.0% | +300.0% |
| 2005 | 7.0% | +75.0% |
| 2006 | 10.0% | +42.9% |
| 2007 | 11.0% | +10.0% |
| 2008 | 16.0% | +45.5% |
| 2009 | 20.0% | +25.0% |
| 2010 | 22.0% | +10.0% |
| 2011 | 24.0% | +9.1% |
| 2012 | 27.0% | +12.5% |
| 2013 | 29.0% | +7.4% |
| 2014 | 33.0% | +13.8% |
| 2015 | 36.0% | +9.1% |
| 2016 | 41.0% | +13.9% |
| 2017 | 46.0% | +12.2% |
| 2018 | 49.0% | +6.5% |
| 2019 | 52.0% | +6.1% |
| 2020 | 54.0% | +3.8% |
| 2021 | 55.0% | +1.9% |
| 2022 | 61.0% | +10.9% |
| 2023 | 67.0% | +9.8% |
| 2024 | 71.0% | +6.0% |
Laos compared with similar countries
- Laos's 71.0% is below the median for lower middle income countries, which is 80.0%, 89% of the median. (39 countries reporting)
- Laos's 71.0% is above the median for East Asia & Pacific, which is 71.0%, 1.0× the median. (15 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female (%) in Laos changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2004 | +300.0% | 1.0% | 4.0% |
| 2005 | +75.0% | 4.0% | 7.0% |
| 2008 | +45.5% | 11.0% | 16.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.7% | 0.0% | 20.0% | 9 |
| 2010s | 35.9% | 22.0% | 52.0% | 10 |
| 2020s | 61.6% | 54.0% | 71.0% | 5 |
Countries ranked near Laos
More gender data for Laos
- Child population (UN estimates and projections) 2,335 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.3716 % change on previous year (2030)
- Population 6,022 (2030)
- Working-age population (UN estimates and projections) 6,022 (2030)
- Population (UN estimates and projections), annual growth rate 1.71 % change on previous year (2030)
- Age population, age 00, female, interpolated 77,014 (2025)
- Age population, age 00, male, interpolated 80,573 (2025)
- Age population, age 01, female, interpolated 76,875 (2025)
- Age population, age 01, male, interpolated 80,330 (2025)
- Age population, age 02, female, interpolated 76,857 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Laos?
- Access to anti-retroviral drugs, female in Laos was 71.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Laos?
- The highest recorded value was 71.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Laos?
- The lowest recorded value was 0.0% in 2000.
- How does Laos rank for access to anti-retroviral drugs, female?
- Laos ranks 81st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Laos?
- Over the last ten years it is up 115.2%. The long-run trend across the full record is volatile.
- Where does this Laos data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.